AMGN News Tuesday, November 3, 2026 +0.70 Positive

Amgen Q3 Adj. EPS $6.45 Beats $5.79 Estimate, Sales $10.365B Beat $10.071B Estimate

Amgen Q3 Adj. EPS $6.45 Beats $5.79 Estimate, Sales $10.365B Beat $10.071B Estimate

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed